Junbo Cao
YOU?
Author Swipe
View article: Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)
Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study) Open
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A) and Precision Treatment Project of Surgical Oncology of Tianjin Medical University Cancer Institute and Hospital (No. ZLWKJZZL14).
View article: Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study
Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study Open
Background: The conversion therapy for advanced hepatocellular carcinoma (HCC) shows promise with a triple therapy approach that combines interventional therapy, immune checkpoint inhibitors, and molecular targeted therapy (primarily small…
View article: Liquid Mulch Can Improve the Yield and Water Use Efficiency of Summer Maize (<i>Zea mays</i> L.) Planted in Furrow‐Ridge Rainwater Harvesting Systems
Liquid Mulch Can Improve the Yield and Water Use Efficiency of Summer Maize (<i>Zea mays</i> L.) Planted in Furrow‐Ridge Rainwater Harvesting Systems Open
The frequent occurrence of drought is an important factor restricting economic as well as sustainable agricultural development. Therefore, to address the issue of seasonal drought during summer in dry semi‐humid areas of Guanzhong Plain, a…
View article: CO hydrogenation conversion driven by micro-environments of active sites over iron carbide catalysts
CO hydrogenation conversion driven by micro-environments of active sites over iron carbide catalysts Open
Essentially clearing the structure–activity relationship between iron carbide catalysts involving multiple active centers to understand the reaction mechanism of CO hydrogenation conversion process is still a great challenge. Here, two mai…
View article: Low expression of miR125a-5p predicts sensitivity to sorafenib by upregulating STAT3 and HTATIP2 in hepatocellular carcinoma
Low expression of miR125a-5p predicts sensitivity to sorafenib by upregulating STAT3 and HTATIP2 in hepatocellular carcinoma Open
Background Sorafenib is a standard of care for systemic therapy of hepatocellular carcinoma (HCC). Further personalized treatment with sorafenib is warranted. The current study aims to identify predictive biomarkers for the efficacy of sor…
View article: Molecular-level insights into the electronic effects in platinum-catalyzed carbon monoxide oxidation
Molecular-level insights into the electronic effects in platinum-catalyzed carbon monoxide oxidation Open
A molecular-level understanding of how the electronic structure of metal center tunes the catalytic behaviors remains a grand challenge in heterogeneous catalysis. Herein, we report an unconventional kinetics strategy for bridging the micr…
View article: Mechanistic aspects of facet-dependent CH4/C2+ selectivity over a χ-Fe5C2 Fischer–Tropsch catalyst
Mechanistic aspects of facet-dependent CH4/C2+ selectivity over a χ-Fe5C2 Fischer–Tropsch catalyst Open
Structure–performance relationship is a complex issue in iron-catalyzed Fischer–Tropsch synthesis, and it is not easy to elucidate it by experimental investigations. First-principle calculation is a powerful method for explaining experimen…